Correction or transfer of immunodeficiency due to TNF-LTα deletion by bone marrow transplantation

Molecular Medicine

Volumn 2, Issue 2, 1996, Pages 247-255

  Müller, Matthias ^a   Eugster, Hans Pietro ^a   Le Hir, Michel ^a   Shakhov, Alexander ^a   Di Padova, Franco ^b   Maurer, Claudine ^b   Quesniaux, Valerie F J ^b   Ryffel, Bernhard ^c  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Sandoz Pharma Ltd   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOTOXIN; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; GENOTYPE; IMMUNE DEFICIENCY; IMMUNOFLUORESCENCE TEST; IRRADIATION; LETHALITY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RADIOSENSITIVITY;

EID: 0029751937     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401621     Document Type: Article

References (32)

1. Aggarwal BB, Vilcek J (eds). Tumor Necrosis Factor, Structure, Function, and Mechanism of Action. Marcel Dekker, New York.
2. Beutler B (ed). Tumour Necrosis Factor: the Molecules and Their Emerging Role in Medicine. Raven, New York.
3. Pennica D, Nedwin GE, Hayflick JS, et al. (1984) Human tumour necrosis factor: Precursor structure, expression and homology to lymphotoxin. Nature 312: 724-729.
4. Pennica D, Hayflick JS, Bringman TS, Palladino MA, Goeddel DV. (1985) Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor. Proc. Natl. Acad. Sci. U.S.A. 82: 6060-6064.
5. Goodwin RG, Alderson MR, Smith CA, et al. (1993) Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell 73: 447-456.
6. Smith CA, Gruss HJ, Davis T, et al. (1993) CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73: 1349-1360.
7. Suda T, Takahashi T, Golstein P, Nagata S. (1993) Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family. Cell 75: 1169-1178.
8. Loetscher H, Pan YC, Lahm HW, et al. (1990) Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 61: 351-359.
9. Schall TJ, Lewis M, Koller KJ, et al. (1990) Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61: 361-370.
10. Beutler B, van Huffel C. (1994) Unraveling function in the TNF ligand and receptor families. Science 264: 667-668.
11. Pfeffer K, Matsuyama T, Kundig TM, et al. (1993) Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73: 457-467.
12. Rothe J, Lesslauer W, Lotscher H, et al. (1993) Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364: 798-802.
13. Erickson SL, de Sauvage FJ, Kikly K, et al. (1994) Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 372: 560-563.
14. Androlewicz MJ, Browning JL, Ware CF. (1992) Lymphotoxin is expressed as a heteromeric complex with a distinct 33-kDa glycoprotein on the surface of an activated human T cell hybridoma. J. Biol. Chem. 267: 2542-2547.
15. Crowe PD, VanArsdale TL, Walter BN, et al. (1994) A lymphotoxin-β-specific receptor. Science 264: 707-710.
16. Baens M, Chaffanet M, Cassiman JJ, vanden-Berghe H, Marynen P. (1993) Construction and evaluation of a hncDNA library of human 12p transcribed sequences derived from a somatic cell hybrid. Genomics 16: 214-218.
17. De Togni P, Goellner J, Ruddle NH, et al. (1994) Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264: 703-707.
18. Eugster HP, Muller M, Karrer U, et al. (1996) Multiple immune abnormalities in tumor necrosis factor and lymphotoxin a double deficient mice. Int. Immunol. 8: 23-26.
19. Espevik T, Nissen-Meyer J. (1986) A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95: 99-105.
20. Kelso A, Glasebrook AL, Kanagawa O, Brunner KT. (1982) Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities. J. Immunol. 129: 550-561.
21. Kelly BS, Levy JG, Sikora L. (1979) The use of the enzyme-linked immunosorbent assay (ELISA) for the detection and quantification of specific antibody from cell cultures. Immunology 37: 45-52.
22. Ryffel B, Car BD, Gunn H, Roman D, Hies-tand P, Mihatsch MJ. (1994) Interleukin-6 exacerbates glomerulonephritis in (NZB × NZW)Fl mice. Am. J. Pathol. 144: 927-937.
23. Vassalli P. (1992) The pathophysiology of tumor necrosis factor. Annu. Rev. Immunol. 10: 411-452.
24. Hunt JS, Chen HL, Hu XL, Chen TL, Morrison DC. (1992) Tumor necrosis factor-α gene expression in the tissues of normal mice. Cytokine 4: 340-346.
25. Freudenberg N, Freudenberg MA, Hoess CD, Schrecker H, Galanos C. (1986) Investigation into the origin of mouse liver sinusoidal cells. Virchows Arch. A Pathol. Anat. Histopathol. 410: 1-7.
26. Banks TA, Rouse BT, Kerley MK, et al. (1995) Lymphotoxin-α-deficient mice: Effects on secondary lymphoid organ development and humoral immune responsiveness. J. Immunol. 155: 1685-1693.
27. Miyawaki S, Nakamura Y, Suzuka H, et al. (1994) A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice. Eur. J. Immunol. 24: 429-434.
28. Castigli E, Alt FW, Davidson L, et al. (1994) CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc. Natl. Acad. Sci. U.S.A. 91: 12135-12139.
29. Renshaw BR, Fanslow WC, Armitage RJ, et al. (1994) Central role of CD40 and its ligand in B lymphocyte responses to T-dependent antigens. J. Exp. Med. 180: 1889-1900.
30. Ghiara P, Boraschi D, Nencioni L, Ghezzi P, Tagliabue A. (1987) Enhancement of in vivo immune response by tumor necrosis factor. J. Immunol. 139: 3676-3679.
31. + T cell clones provides a costimulatory signal for human B cell activation. J. Exp. Med. 177: 1575-1585.
32. Del-Prete G, De-Carli M, D'Elios MM, et al. (1994) Polyclonal B cell activation induced by herpesvirus saimiri-transformed human CD4+ T cell clones. Role for membrane TNF-alpha/TNF-alpha receptors and CD2/ CD58 interactions. J. Immunol. 153: 4872-4879.